Calcimimetic compound for use in the treatment of epithelial injury

Details for Australian Patent Application No. 2009228069 (hide)

Owner Yale University Amgen Inc.

Inventors Ng, Gordon; Martin, David; Viney, Joanne L.; Richards, William G.; Geibel, John Peter; Hebert, Steven Charles; Herbert, Patricia, R.

Agent Shelston IP

Pub. Number AU-A-2009228069

PCT Pub. Number WO2009/121015

Priority 61/072,264 28.03.08 US

Filing date 27 March 2009

Wipo publication date 1 October 2009

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/42 (2006.01) - Oxazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 17/02 (2006.01) Drugs for dermatological disorders

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/121015 Priority application(s): WO2009/121015

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228074-A dry powder inhalation system

2009228062-Low emission power generation and hydrocarbon recovery systems and methods